Plain-English translation of NCT06955715 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This small pilot study is testing whether pasteurized donor human milk can be a safe and helpful supplement for babies born to mothers living with HIV. The milk comes from a milk bank in Calgary and is provided to families over about 6-8 weeks starting when babies are around 2 months old. Researchers want to see how well babies tolerate the milk and how it affects their growth and feeding.
Babies born to mothers with HIV need safe feeding options, and this medication may provide a supportive option for families who want to supplement formula feeding or breastfeeding with donated breast milk rather than relying on formula alone.
You likely qualify if…
You likely don't qualify if…
You would receive four home visits over 6-8 weeks starting when your baby is about 2 months old. At each visit, researchers deliver frozen donated breast milk (either 25 bottles if you're formula feeding or 8 bottles if you're breastfeeding) and pick up empty bottles from the previous delivery. You would keep a simple log of how much milk you give your baby each day and watch for any signs that your baby isn't tolerating it well. You'll also get a weekly phone call to check in and answer any questions, and your baby's weight will be measured at the first and last visits to track growth.
AI-generated summary from trial data · Jun 23, 2026 · Not medical advice
Canada